Tert-Butyl Formate

Tert-Butyl Formate

SCHEMBL27721997

CC(C)(C)OC=O.CC1CCN(C)CC1

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 1/20 0.50
▸ ALDH1A1 P00352 1/20 0.33
▸ POLB P06746 1/20 0.33
▸ GAA P10253 2/20 0.32
▸ LMNA P02545 1/20 0.32
▸ HPGD P15428 1/20 0.32
▸ SIGMAR1 Q99720 1/20 0.31
▸ MEN1 O00255 1/20 0.31
▸ KMT2A Q03164 1/20 0.31
▸ HRH3 Q9Y5N1 2/20 0.31
▸ MAOB P27338 1/20 0.31
▸ CHRM3 P20309 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tert-Butyl Formate SCHEMBL27611304 0.83 TDP1 (0.48) TDP1
Tert-Butyl Formate SCHEMBL27993015 0.83 TDP1 (0.48) TDP1ALDH1A1GAAMEN1KMT2A
Tert-Butyl Formate SCHEMBL28313648 0.83 TDP1 (0.48) TDP1ALDH1A1POLBGAALMNA
Tert-Butyl Formate SCHEMBL27660032 0.80 TDP1 (0.45) TDP1POLB
Formic Acid Methyl Ester SCHEMBL29248738 0.79 ALDH1A1 (0.33) ALDH1A1POLBGAAMEN1KMT2A
Tert-Butyl Formate SCHEMBL28792406 0.79 TDP1 (0.59) TDP1
Tert-Butyl Formate SCHEMBL28267336 0.79 TDP1 (0.59) TDP1ALDH1A1
Tert-Butyl Formate SCHEMBL28276350 0.78 TDP1 (0.56) TDP1KMT2A
Tert-Butyl Formate SCHEMBL27767519 0.78 TDP1 (0.56) TDP1
Tert-Butyl Formate SCHEMBL27361307 0.78 TDP1 (0.56) TDP1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101309918-B [4-(benzo[b]thiophen-2-yl)-pyrimidin-2-yl]-amine derivatives as ikk-beta inhibitors for the treatment of cancer and inflammatory diseases LILLY CO ELI 2010-12-29 — — CN disclosed
CN-101309918-A [4-(benzo[b]thiophen-2-yl)-pyrimidin-2-yl]-amine derivatives as ikk-beta inhibitors for the treatment of cancer and inflammatory diseases LILLY CO ELI (US) 2008-11-19 — — CN disclosed
Send feedback